Research Collaboration Sample Clauses

Research Collaboration. Subject to the terms and conditions of this Agreement UG and SGX will use commercially reasonable efforts to perform under the Research Plan attached to this Agreement as Exhibit B ("Research Plan"), based on the budget attached as Exhibit B1 ("Research Budget"). Research Plan activities will be overseen by the JRC. The JRC will review the Research Plan on an ongoing basis and may make changes to the Research Plan then in effect, provided that the JRC may not increase the applicable Research Budget without the written approval of each Party. On an annual basis commencing on the first anniversary of the Effective Date and continuing until the conclusion of the Parties' activities under the Research Plan, the JRC shall review the Research Budget to ensure that the number of full time equivalent personnel (FTEs) of each Party engaged under the Research Plan and the other costs of the Research Plan activities, are being shared between the Parties on a 50/50 basis, and shall make adjustments to each Party's responsibilities under the Research Plan in order to effect such sharing to the greatest extent possible, taking into account each Party's experience and expertise in the various Research Plan activities.

Research Collaboration. 2.1 SELECTION OF TARGETS FOR INCLUSION INTO THE RESEARCH COLLABORATION. (a) Initial [**] Targets. Within thirty (30) days following the Effective Date, and from time to time thereafter, Alnylam shall provide to the Gatekeeper a list of Targets that are Blocked Targets (a "Blocked Target List"). During the Selection Term, Novartis may from time to time deliver to the Gatekeeper one or more lists of Targets (each such list, a "Target List") that Novartis desires to include in the Research Collaboration. Within two (2) days following the Gatekeeper's receipt of the Target List, the Gatekeeper shall notify Novartis in writing (a "Target Response Notice") which, if any, of the Targets identified on such Target List are on the Blocked Target List most recently delivered by Alnylam to the Gatekeeper. All of the Targets on the Target List that are not on such Blocked Target List shall be deemed "Selected Targets" for the purposes of this Agreement, and the Gatekeeper shall notify both Parties of the identity of such Selected Targets within the same two (2) day time period. Selected Targets that are or have been the subject of an Active Program shall be deemed to be on the "A List," and Selected Targets that are not nor have not been the subject of an Active Program shall be deemed to be on the "B List." Subject to Section 2.1(b), Novartis shall be entitled to submit Targets for designation as Selected Targets until an aggregate of [**] Selected Targets (the "Selected Target Threshold") have been identified pursuant to the foregoing procedure. Novartis shall submit the first Target List, which shall contain at least [**] Targets, within [**] after the Effective Date. Without limiting the provisions of Sections 2.6(b) and (c), the Parties agree that none of the genes of respiratory syncytial virus (RSV) shall be available as a "Selected Target" under the provisions of this Section 2.1.

Research Collaboration. (a) GSK hereby grants to Anacor a non-exclusive, non-royalty bearing license under the GSK IP, solely as and to the extent necessary or important to conduct activities for which Anacor is responsible under the Research Plans during the Research Collaboration Term. (b) Anacor hereby grants to GSK a non-exclusive, non-royalty bearing license under the Anacor IP, solely as and to the extent necessary or important to conduct activities for which GSK is responsible under the Research Plans during the Research Collaboration Term.

Research Collaboration. 3.7.1 Aarvik shall carry out the activities of each Work Item and deliver the required Data Package and/or deliverables in accordance with the applicable SOW. Without limiting the generality of the foregoing, Aarvik shall, in accordance with the applicable SOWs and the timeline approved by JRC, apply the Aarvik IP to (i) design and synthesize Collaboration Compounds, and (ii) by itself or through subcontractor(s), [***]. During the Research Term, if any Party identifies any Third Party Patent or Know-How that is necessary or reasonably useful for any activity under the SOWs but has not been included in the Aarvik IP, then such Party shall immediately inform the other Party and the Parties shall discuss in good faith the need of obtaining a license from such Third Party. 3.7.2 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver the Data Packages and all other deliverables required under the [***], as well as the results of the Patentability and FTO Analysis as described in Section 3.2.3, to ArriVent. ArriVent shall have the sole discretion to decide whether or not to advance any Collaboration Compound and which Collaboration Compound(s) will be advanced for further studies beyond the [***]. ArriVent shall inform Axxxxx of its decision in writing. If AxxxXxxx decides to advance the Collaboration Program to [***], ArriVent shall make the payment for the [***] pursuant to Section 6.2.1. 3.7.3 If, upon completion of the [***] for the Collaboration Program, AxxxXxxx decides not to advance the Collaboration Program to [***], ArriVent may terminate the Collaboration Program. If AxxxXxxx decides to advance the Collaboration Program to [***], ArriVent shall make the payment for the [***] pursuant to Section 6.2.1. 3.7.4 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver all Data Packages and deliverables required under the [***] to ArriVent. ArriVent shall have the sole discretion to decide whether or not to advance any Collaboration Compound and which Collaboration Compound(s) will be advanced for further studies beyond the [***]. ArriVent shall inform Axxxxx of its decision in writing. 3.7.5 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver all Data Packages and deliverables required under the [***] to ArriVent. 3.7.6 W...

Research Collaboration. Joint research programs will be developed, which will lead to joint research projects, joint publications, and faculty and graduate student exchanges. Traveling and accommodation expenses for exchanges or visits involving faculty will be the responsibility of the Institution, or Faculty or Department of that Institution, whose staff are undertaking the exchange or visit. The initial funding for research, faculty exchange and graduate student research projects will be the responsibility of each institution, but the Institutions will endeavor to develop joint funding opportunities in the future (e.g. US NSF, USDA and other relevant federal agencies and private institutions). Faculty of both Institutions will identify projects of mutual interest. The specific areas of research collaboration will initially focus on

Research Collaboration. Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.

Research Collaboration. Subject to the terms and conditions set forth herein, University hereby agrees to use its best efforts to collaborate with XYZ in pursuing the Research Project and undertake its own responsibilities set forth in Schedule 2, provided that XYZ shall perform its own responsibilities set forth in Schedule 2.

Research Collaboration. 2.1 BDSI will provide to ***** soy-derived phosphatidylserine at its cost to manufacture the product. ***** will provide at least one process-sensitive ingredient, as well as manufacturing facilities and personnel to encochleate the process-sensitive ingredient with instruction and know how from BDSI and to incorporate the encochleated process-sensitive ingredient into a finished `food product. 2.2 BDSI and ***** will jointly conduct the Research Plan ("RP") outlined in Appendix A. 2.3 will pay all reasonable expenses associated with the RP as outlined in Appendix B.

Research Collaboration. GIT and <INSERT Abbreviated Name of Int’l School/Entity HERE> will initiate collaborative activities contingent upon successful negotiation and execution of appropriate agreements at a later date, which shall outline the terms and conditions applicable to each activity, and as GIT is permitted under U.S. export laws and regulations, and as <INSERT Abbreviated Name of Int’l School/Entity HERE> is permitted under its country’s laws. The Parties understand and agree that the Georgia Tech Research Corporation (GTRC) is a cooperative organization of GIT and shall enter into any research agreements on behalf of GIT. Joint research projects may be explored by appropriate faculty members with the approval of the Parties according to the established procedures at each institution.

Research Collaboration. The Research Collaboration shall be carried out in accordance with the Research Collaboration Plan, as detailed in Exhibit A, as may be amended from time to time by the Steering Committee during the Research Term. The Research Term shall begin on the Effective Date and end December 31, 2005, unless earlier terminated pursuant to Article XII ("Research Term"). The Research Term may be amended by the Parties consistent with the terms of the Agreement.